{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:27:44Z","timestamp":1782973664709,"version":"3.54.5"},"reference-count":33,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2009,6,9]],"date-time":"2009-06-09T00:00:00Z","timestamp":1244505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> There are concerns that there is no uniform approach towards the management of vitiligo.<\/jats:p><jats:p><jats:bold>Objectives\u2002<\/jats:bold> To explore attitudes and strategies for the management of vitiligo among dermatologists.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> A self\u2010administered questionnaire containing 22 questions was distributed to 160 dermatologists attending a national dermatology conference in 2007.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> One hundred and twelve dermatologists responded to the questionnaire (70% response rate). We had 105 completed questionnaires (seven were excluded due to incompleteness). Active treatment of vitiligo was recommended by 96% in more than half of patients, while 79% recommended treatment at non\u2010visible sites. Repigmentation was regarded as main treatment goal by 54%. Mid\u2010potent topical steroids were widely prescribed for focal vitiligo (72% in children and 65% in adults). Use of tacrolimus and pimecrolimus was limited. The most common used phototherapy was \u2018narrowband ultraviolet B\u2019 (NBUVB; 36% and 40% for generaliased vitiligo in children and adults, respectively). The use of oral psoralen plus UVA (PUVA) was limited (8% for generalized vitiligo in adults). Few respondents (1\u20138% for different types of vitiligo) prescribed outdoor topical PUVA. Vitiligo surgery was advised mainly for segmental type (18% in adults and 5% in children). Depigmentation was the first option for universal vitiligo by 50% and 30% in adults and children, respectively.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Most dermatologists are enthusiastic about active treatment of vitiligo even in hidden sites. Overall, the most two common treatment modalities were topical steroids and NBUVB. Vitiligo surgery is underutilized. Development of national practice guidelines is needed.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2009.03310.x","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T04:19:00Z","timestamp":1244607540000},"page":"1282-1288","source":"Crossref","is-referenced-by-count":10,"title":["A survey of vitiligo management among dermatologists in Saudi Arabia"],"prefix":"10.1111","volume":"23","author":[{"given":"KM","family":"AlGhamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,8]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"1","article-title":"An update on new and emerging options for the treatment of vitiligo","volume":"13","author":"Mahmoud BH","year":"2008","journal-title":"Skin Ther Lett"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565040-00002"},{"key":"e_1_2_7_4_2","first-page":"903","volume-title":"Dermatology in General Medicine","author":"Mosher DB","year":"1993"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2004.07.026"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archinte.1992.00400170036007","article-title":"Practice guidelines: a new reality in medicine. II. Methods of developing guidelines","volume":"152","author":"Woolf SH","year":"1992","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00004.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00822.x"},{"key":"e_1_2_7_9_2","first-page":"177","article-title":"Management of vitiligo patients and attitude of dermatologists towards vitiligo","volume":"14","author":"Ongenae K","year":"2004","journal-title":"Eur J Dermatol"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90691-X"},{"key":"e_1_2_7_11_2","first-page":"100","article-title":"Resultaten van een enqueete onder vitiligo patienten","volume":"6","author":"Westerhof W","year":"1996","journal-title":"Ned Tijdschr Dermatol Venereol"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00162.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00320.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550510025579"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.5.581"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.12.031"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-4179(00)00039-5"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01462.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.6.730"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01413.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.5.578"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01477.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20057"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/pho.2006.24.354"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.01980.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.12.1582"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00815.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70247-6"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1996.tb00010.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057881"},{"key":"e_1_2_7_31_2","first-page":"66","article-title":"Safety and therapeutic effectiveness of 8\u2010methoxypsoralen, 4,5,8\u2010 trimethylpsoralen, and psoralen in vitiligo","author":"Pathak MA","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"key":"e_1_2_7_32_2","first-page":"1022","article-title":"Phototherapy with UV\u2010B in vitiligo","volume":"65","author":"Koster W","year":"1990","journal-title":"Zeitschr Hautkrank"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890480045006"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1994.tb02859.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2009.03310.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2009.03310.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T22:41:52Z","timestamp":1697064112000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2009.03310.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,8]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1468-3083.2009.03310.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03310.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,8]]}}}